CollPlant Biotechnologies has signed a definitive agreement to acquire LightSolver, moving the Nasdaq-listed regenerative medicine company into photonic computing and supercomputing through an equity-heavy transaction tied to technological and commercial milestones.
LightSolver is developing the Laser Processing Unit, or LPU, an all-optical computing architecture that uses interactions among lasers to perform computation.
The company is targeting commercial availability of the platform in 2028.
Rather than using electronic transistors for all mathematical operations and data movement, LightSolver maps mathematical problems onto an optical system where large numbers of variables can interact simultaneously.
The company is targeting workloads spanning scientific simulation, optimization, partial differential equations, engineering, Physical AI, aerospace, defense, energy and financial services.
Commercial validation is already underway.
LightSolver has a funded engineering relationship with Boeing focused on physics-based aerospace simulations and is also working with engineering software companies, defense organizations and other design partners on simulation and optimization workloads.
CollPlant will issue 3,734,476 ordinary shares at or around closing, equal to approximately 19.7% of its issued share capital immediately before signing.
The transaction also includes pre-funded warrants covering 6,134,363 shares, milestone-based warrants covering up to 224,078,345 shares and rollover options covering another 2,261,966 shares.
The milestone warrants carry a $0.00001 exercise price and become exercisable upon achievement of specified technology and commercial objectives. Certain issuances remain subject to shareholder approval under Nasdaq rules.
CollPlant said it will remain committed to regenerative medicine while using LightSolver to establish a second growth platform in high-performance computing.
KEY QUOTES:
“Computing is reaching an inflection point. We believe the next great leap will come not from making transistors smaller, but from changing the very medium of computing, from electrons to light.”
Dr. Ruti Ben Shlomi, Founder And CEO Of LightSolver
“This transaction marks CollPlant’s entry into a market with massive growth potential, executed through a highly disciplined approach to capital allocation.”
Eran Rotem, Deputy CEO And CFO Of CollPlant
